Order Article Reprints

Jurutka PW, di Martino O, Reshi S, Mallick S, Sausedo MA, Moen GA, Lee IJ, Ivan DJ, Krall TD, Peoples SJ, et al. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. International Journal of Molecular Sciences. 2022; 23(24):16213. https://doi.org/10.3390/ijms232416213

Jurutka, Peter W., Orsola di Martino, Sabeeha Reshi, Sanchita Mallick, Michael A. Sausedo, Grant A. Moen, Isaac J. Lee, Dominic J. Ivan, Tyler D. Krall, Samuel J. Peoples, and et al. 2022. "An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene" International Journal of Molecular Sciences 23, no. 24: 16213. https://doi.org/10.3390/ijms232416213

Jurutka, P. W., di Martino, O., Reshi, S., Mallick, S., Sausedo, M. A., Moen, G. A., Lee, I. J., Ivan, D. J., Krall, T. D., Peoples, S. J., Perez, A., Tromba, L., Le, A., Khadka, I., Petros, R., Savage, B. M., Salama, E., Salama, J., Ziller, J. W., ... Wagner, C. E. (2022). An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. International Journal of Molecular Sciences, 23(24), 16213. https://doi.org/10.3390/ijms232416213